Capital International Investors Royalty Pharma PLC Transaction History

Capital International Investors

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$32.77 - $39.4 $6,193 - $7,446	189 Added 0.0%	3,831,349 $138 Million
Q4 2022 Feb 14, 2023	SELL	$39.17 - $44.04 $45.7 Million - $51.4 Million	-1,167,182 Reduced 23.35%	3,831,160 $151 Million
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $148,951 - $166,767	3,735 Added 0.07%	4,998,342 $201 Million
Q2 2022 Aug 15, 2022	BUY	$37.53 - $44.22 $38,168 - $44,971	1,017 Added 0.02%	4,994,607 $210 Million
Q1 2022 May 16, 2022	BUY	$37.46 - $42.44 $179,733 - $203,627	4,798 Added 0.1%	4,993,590 $195 Million
Q4 2021 Feb 14, 2022	BUY	$35.17 - $42.48 $46,600 - $56,285	1,325 Added 0.03%	4,988,792 $199 Million
Q3 2021 Nov 15, 2021	SELL	$36.14 - $42.24 $432 Million - $505 Million	-11,955,241 Reduced 70.56%	4,987,467 $180 Million
Q2 2021 Aug 16, 2021	BUY	$39.85 - $46.63 $19.7 Million - $23 Million	493,607 Added 3.0%	16,942,708 $694 Million
Q1 2021 May 14, 2021	SELL	$42.34 - $52.82 $95,349 - $118,950	-2,252 Reduced 0.01%	16,449,101 $718 Million
Q4 2020 Feb 12, 2021	BUY	$36.12 - $50.05 $220 Million - $304 Million	6,077,310 Added 58.58%	16,451,353 $823 Million
Q3 2020 Nov 13, 2020	BUY	$38.56 - $48.36 $86.3 Million - $108 Million	2,236,988 Added 27.49%	10,374,043 $436 Million
Q2 2020 Aug 14, 2020	BUY	$44.5 - $52.11 $362 Million - $424 Million	8,137,055 New	8,137,055 $395 Million

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

Stay updated on Capital International Investors with notifications on news.